We drive innovation in oncology and solid organ disease through development of advanced treatment and early interception.
Total raised: $45.8M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2025 | - | $45.8M | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.03.2025 | RegCell Raises $45.8M in Funding | . RegCell, an Emeryville, CA-based biotechnology company developing therapies for autoimmune diseases and transplantation, raised $45.8M in funding. The round consisted of $8.5M in Seed funding led by The University of Tokyo Edge Capital Pa... |